Airway Transcutaneous CO2 Monitoring Jet Ventilation

🫁 As cannabis products increasingly appear in patients’ medication lists, clinicians managing sedation and anesthesia should remain alert to potential airway and respiratory complications during procedures requiring jet ventilation or other assisted breathing techniques. The cannabinoid profile of consumed products—particularly the ratio of THC to CBD and the presence of other phytoconstituents—may influence respiratory depression, airway reactivity, and carbon dioxide retention in ways that transcutaneous monitoring can help detect early. However, current evidence on cannabinoid effects during procedural sedation remains limited, with most safety data derived from non-medical contexts or animal models rather than controlled clinical trials in sedated populations. When obtaining a cannabis use history, clinicians should document not only frequency and route of use but also product type and composition when feasible, and consider whether transcutaneous CO2 monitoring offers added safety margins in patients with recent or regular cannabis use undergoing procedures requiring airway management.